TPST - Financial Reports List - Tempest Therapeutics, Inc. - IntrinsicAlpha

Tempest Therapeutics, Inc. TPST

Healthcare - Biotechnology - NASDAQ - US

$ 7.58

-2.34 %

$ 26.7 M

Market Cap

-0.36

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-84.47%	-85.23%
Annual Report	FY	10-K	2024-12-31	0.00%	-41.88%	100.00%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-55.56%	-60.06%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-26.24%	-28.27%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	1.63%	-5.18%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	25.09%	15.89%
Annual Report	FY	10-K	2023-12-31	0.00%	19.81%	15.83%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	25.62%	24.84%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	20.72%	14.86%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	8.91%	7.11%

1